THE THERAPEUTIC Goods Administration (TGA) has approved the world’s first intradermal (ID) influenza vaccine, Intanza, for the prevention of seasonal influenza in adults and the elderly
02/04/2009
The Centers for Disease Control and Prevention (CDC) has released specific recommendations for dental healthcare professionals to prevent transmission of the 2009 H1N1 Influenza virus.
26/11/2009
US researchers report that the 2009 H1N1 Influenza virus can damage cells throughout the respiratory airway, as discovered from autopsies of fatal cases. The damage seen is much like that of earlier influenza pandemics in 1918 and 1957.
11/12/2009
The National Institute of Allergy and Infectious Diseases (NIAID) has released a study suggesting that adults exposed to strains of seasonal H1N1 virus circulating in the population since 1988 may be more able to fight the severity of infection caused by the 2009 H1N1 influenza virus.
18/11/2009
The Strategic Advisory Group of Experts (SAGE) on Immunization, which advises WHO on policies and strategies for vaccines and immunization, met in Geneva last week to discuss policies and strategies for the pandemic (H1N1) vaccine. The experts also made recommendations on the formulation of seasonal influenza vaccines for the southern hemisphere in 2010.
02/11/2009
THE CENTRES for Disease Control and Prevention (CDC) has reported additionally confirmed human infections of the Swine Influenza in the United States and internationally.
30/04/2009
The US Centers for Disease Control and Prevention (CDC) has updated its information regarding how to use the CSL 2009 H1N1 monovalent vaccine. It has also issued guidance on dose spacing and administration with other vaccines.
23/11/2009
Australia's Therapeutic Goods Administration (TGA) has been closely monitoring any side effects from the use of the Panvax vaccine since its approval for the national immunisation program.
24/11/2009
The Therapeutic Goods Administration (TGA) has approved for registration the Australian-made Panvax H1N1 Vaccine Junior enabling children from 6 months to 9 years of age to be protected against the pandemic H1N1 influenza.
04/12/2009
The World Health Organisation (WHO) has collated vaccination information from 16 of around 40 countries, including Australia, that are carrying out national H1N1 pandemic vaccine campaigns.
23/11/2009
The Australian Government has allocated a share of $108m to 15 medical research teams across the country.
10/02/2009
Guidelines concerning amantadine, oseltamivir and zanamivir for the treatment of influenza have been updated by the Agency for Healthcare Research and Quality (AHRQ), an agency under the US Department of Health and Human Services.
28/01/2010
The World Health Organisation (WHO) has published its latest update to the international situation regarding the 2009 H1N1 Influenza.
12/02/2010
The Food and Drug Administration (FDA) publishes a listing of fraudulent 2009 H1N1 Influenza products that have not been approved for diagnosis, prevention or treatment.
27/11/2009
ALCON has launched a website as an online resource for Patanase nasal allergy treatment.
20/03/2009
HIV-positive adults are being recruited to participate in a clinical trial of the 2009 H1N1 influenza vaccine. The US study will involve 240 men and women of 18 - 64 years of age.
14/12/2009
STERLIN has commented on the UK Health Protection Agency’s testing guidelines for H1N1 Influenza, believing its Copan’s Universal Transport Medium (UTM) meets the mark.
05/06/2009
As at 31 December 2009, of the 6 million doses of Panvax distributed in Australia, there were 1289 suspected side effects reported to the Therapeutic Goods Administration (TGA) following vaccination.
01/03/2010
The American Society for Microbiology (ASM) has published interim guidelines to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1.
30/10/2009
THE VICTORIAN government is currently facing a tough decision as how to handle the current H1N1 influenza (swine flu) outbreak, with a pandemic plan which fails to fit the characteristics of the virus.
04/06/2009